GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Price-to-Owner-Earnings

Accelerated Pharma (Accelerated Pharma) Price-to-Owner-Earnings : (As of May. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Price-to-Owner-Earnings?

As of today (2024-05-20), Accelerated Pharma's share price is $0.00. Accelerated Pharma does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Accelerated Pharma's Price-to-Owner-Earnings or its related term are showing as below:


ACCP's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 28.27
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-20), Accelerated Pharma's share price is $0.00. Accelerated Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2017 was $0.00. Therefore, Accelerated Pharma's PE Ratio for today is N/A.

As of today (2024-05-20), Accelerated Pharma's share price is $0.00. Accelerated Pharma's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, Accelerated Pharma's PE Ratio without NRI for today is N/A.


Accelerated Pharma Price-to-Owner-Earnings Historical Data

The historical data trend for Accelerated Pharma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Price-to-Owner-Earnings Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
Price-to-Owner-Earnings
- - -

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Accelerated Pharma's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerated Pharma's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Price-to-Owner-Earnings falls into.



Accelerated Pharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Accelerated Pharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerated Pharma  (NAS:ACCP) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Accelerated Pharma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines